Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Rachel L. Morehouse is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Light and Ion Treatment to Enhance Medication Efficacy in Depression (LITE+MED): A Randomized Controlled Trial of Light and Fluoxetine in Nonseasonal Major Depression
Lam, R. W. R. W. (PI), Beaulieu, S. S. (CoPI), Cheung, A. (CoPI), Enns, M. W. M. (CoPI), Kiss, A. (CoPI), Levitan, R. D. R. D. (CoPI), Levitt, A. J. A. J. (CoPI), Michalak, E. E. (CoPI), Morehouse, R. L. (CoPI) & Parikh, S. V. (CoPI)
Institute of Neurosciences, Mental Health and Addiction
1/1/09 → 3/31/13
Project: Research project
-
Functional outcomes with bright light in monotherapy and combined with fluoxetine in patients with major depressive disorder: Results from the LIFE-D trial
Li, V. W., Morton, E., Michalak, E. E., Tam, E. M., Levitt, A. J., Levitan, R. D., Cheung, A., Morehouse, R., Ramasubbu, R., Yatham, L. N. & Lam, R. W., Jan 15 2022, In: Journal of Affective Disorders. 297, p. 396-400 5 p.Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus) -
Incidences sur la qualité de vie du traitement lumineux et de la fluoxétine combinés chez les patients souffrant de trouble dépressif majeur non saisonnier: Un essai clinique randomisé
Translated title of the contribution :Quality of Life Impacts of Bright Light Treatment, Fluoxetine, and the Combination in Patients with Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial Research output: Contribution to journal › Article › peer-review
11 Citations (Scopus) -
Appetitive symptoms differentially predict treatment response to fluoxetine, light, and placebo in nonseasonal major depression
Levitan, R. D., Levitt, A. J., Michalak, E. E., Morehouse, R., Ramasubbu, R., Yatham, L. N., Tam, E. M. & Lam, R. W., Jul 1 2018, In: Journal of Clinical Psychiatry. 79, 4, 17m11856.Research output: Contribution to journal › Article › peer-review
6 Citations (Scopus) -
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 5. Complementary and Alternative Medicine Treatments
Ravindran, A. V., Balneaves, L. G., Faulkner, G., Ortiz, A., McIntosh, D., Morehouse, R. L., Ravindran, L., Yatham, L. N., Kennedy, S. H., Lam, R. W., MacQueen, G. M., Milev, R. V. & Parikh, S. V., Sept 2016, In: Canadian Journal of Psychiatry. 61, 9, p. 576-587 12 p.Research output: Contribution to journal › Review article › peer-review
Open Access275 Citations (Scopus) -
Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder a randomized clinical trial
Lam, R. W., Levitt, A. J., Levitan, R. D., Michalak, E. E., Cheung, A. H., Morehouse, R., Ramasubbu, R., Yatham, L. N. & Tam, E. M., Jan 2016, In: JAMA Psychiatry. 73, 1, p. 56-63 8 p.Research output: Contribution to journal › Article › peer-review
Open Access205 Citations (Scopus)